Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019042445) COMPOUND HAVING BRUTON'S TYROSINE KINASE (BTK)-INHIBITION AND DEGRADATION ACTIVITY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/042445 International Application No.: PCT/CN2018/103710
Publication Date: 07.03.2019 International Filing Date: 02.09.2018
IPC:
C07D 487/04 (2006.01) ,A61K 31/519 (2006.01) ,A61P 35/00 (2006.01) ,A61P 35/02 (2006.01) ,A61P 37/02 (2006.01) ,A61P 19/02 (2006.01) ,A61P 17/06 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
487
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
02
specific for leukemia
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
02
Immunomodulators
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19
Drugs for skeletal disorders
02
for joint disorders, e.g. arthritis, arthrosis
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17
Drugs for dermatological disorders
06
Antipsoriatics
Applicants:
上海美志医药科技有限公司 SHANGHAI MEIZER PHARMACEUTICALS CO., LTD. [CN/CN]; 中国上海市 浦东新区万祥镇宏祥北路83弄1-42号20幢118室 Room 118 Building 20, No. 1-42, Lane 83, Hongxiang North Road Wanxiang Town, Pudong New Area Shanghai 201313, CN
Inventors:
舒永志 SHU, Yongzhi; CN
Agent:
上海德禾翰通律师事务所 DEHEHANTONG LAW FIRM; 中国上海市 徐汇区宜山路425号光启城2102室 Room 2102 21st Floor, Pole Tower, No. 425 Yishan Rd., Xuhui District Shanghai 200233, CN
Priority Data:
201710783076.X03.09.2017CN
Title (EN) COMPOUND HAVING BRUTON'S TYROSINE KINASE (BTK)-INHIBITION AND DEGRADATION ACTIVITY
(FR) COMPOSÉ AYANT UNE ACTIVITÉ D'INHIBITION ET DE DÉGRADATION DE LA TYROSINE KINASE DE BRUTON (BTK)
(ZH) 一类具有抑制并降解布鲁顿酪氨酸蛋白激酶Btk活性的化合物
Abstract:
(EN) A compound having Bruton's tyrosine kinase (Btk)-inhibition and degradation activity as represented by formula I. The compound has excellent Btk-inhibition activity and can degrade Btk, and can be used for preparing drugs for treatment of Btk activity-related diseases. (I)
(FR) La présente invention concerne un composé ayant une activité d'inhibition et de dégradation de la tyrosine kinase de Bruton (Btk) tel que représenté par la formule I. Le composé présente une excellente activité d'inhibition de Btk, peut dégrader cette dernière, et peut être utilisé pour préparer des médicaments pour le traitement de maladies liées à l'activité de Btk. (I)
(ZH) 一类具有抑制并降解布鲁顿酪氨酸蛋白激酶Btk活性的式I化合物,其具有很好的Btk抑制活性并能将Btk降解,可以用于制备治疗间Btk活性相关的疾病的药物。 (I)
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)